Skyrocketing Demand for GLP-1 Medications Strains Employers
Immediate reaction In recent months, employers across the United States have begun to express serious concerns over a significant rise in the demand for glucagon-like peptide-1 (GLP-1) medications. Used primarily for managing type 2 diabetes and, more recently, for weight loss, these drugs have surged in popularity due to their effectiveness. As more employees seek…











